Aptahem AB (publ)
Stockholm Stock Exchange APTA.ST
Aptahem AB (publ) Total Non-Current Liabilities for the year ending December 31, 2023
Aptahem AB (publ) Total Non-Current Liabilities is NA for the year ending December 31, 2023. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.
Key data
| Date | Total Non-Current Liabilities | Shareholders' Equity | Other Liabilities | Total Liabilities |
|---|
Market news
Loading...
Stockholm Stock Exchange: APTA.ST
| CEO | Mr. Mikael Lindstam |
| IPO Date | April 17, 2015 |
| Location | Sweden |
| Headquarters | Norra Vallgatan 58, 4TR |
| Employees | 5 |
| Sector | Health Care |
| Industries | |
Description
Aptahem AB (publ), a clinical stage biotechnology company, develops aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions. Its principal pharmaceutical candidate is Apta-1, which is in preclinical stage to prevent mortality rate caused by organ and tissue damage in sepsis patients. The company has collaborations with various academic groups, including Consortium with Orebro University, Seattle Children's Research Institute, and University Health Network. Aptahem AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email